- Home
- CLRO vs BIAF Comparison
CLRO vs BIAF Comparison
Compare CLRO & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRO
- BIAF
- Stock Information
- Founded
- CLRO 1983
- BIAF 2014
- Country
- CLRO United States
- BIAF United States
- Employees
- CLRO N/A
- BIAF N/A
- Industry
- CLRO Radio And Television Broadcasting And Communications Equipment
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CLRO Technology
- BIAF Health Care
- Exchange
- CLRO Nasdaq
- BIAF Nasdaq
- Market Cap
- CLRO 7.5M
- BIAF 7.6M
- IPO Year
- CLRO N/A
- BIAF 2022
- Fundamental
- Price
- CLRO $4.97
- BIAF $0.35
- Analyst Decision
- CLRO
- BIAF Hold
- Analyst Count
- CLRO 0
- BIAF 1
- Target Price
- CLRO N/A
- BIAF N/A
- AVG Volume (30 Days)
- CLRO 96.9K
- BIAF 10.4M
- Earning Date
- CLRO 11-14-2025
- BIAF 11-13-2025
- Dividend Yield
- CLRO N/A
- BIAF N/A
- EPS Growth
- CLRO N/A
- BIAF N/A
- EPS
- CLRO N/A
- BIAF N/A
- Revenue
- CLRO $9,689,000.00
- BIAF $7,681,059.00
- Revenue This Year
- CLRO N/A
- BIAF N/A
- Revenue Next Year
- CLRO N/A
- BIAF $20.04
- P/E Ratio
- CLRO N/A
- BIAF N/A
- Revenue Growth
- CLRO N/A
- BIAF 4.99
- 52 Week Low
- CLRO $3.83
- BIAF $0.16
- 52 Week High
- CLRO $21.00
- BIAF $2.26
- Technical
- Relative Strength Index (RSI)
- CLRO 55.11
- BIAF 73.86
- Support Level
- CLRO $4.09
- BIAF $0.24
- Resistance Level
- CLRO $5.01
- BIAF $0.27
- Average True Range (ATR)
- CLRO 0.41
- BIAF 0.03
- MACD
- CLRO 0.17
- BIAF 0.01
- Stochastic Oscillator
- CLRO 77.22
- BIAF 54.52
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.